These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical profile of the novel antidepressant bupropion. Stern WC; Harto-Truax N; Rogers J; Miller L Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060 [No Abstract] [Full Text] [Related]
3. Side effects and the "blindability" of clinical drug trials. White K; Kando J; Park T; Waternaux C; Brown WA Am J Psychiatry; 1992 Dec; 149(12):1730-1. PubMed ID: 1443253 [TBL] [Abstract][Full Text] [Related]
4. What conditions are necessary to assess antidepressant efficacy? Quitkin FM; Klein DF Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690 [No Abstract] [Full Text] [Related]
5. Pills or placebos? Weissman MM Science; 1999 May; 284(5416):915. PubMed ID: 10357676 [No Abstract] [Full Text] [Related]
6. European perspectives in psychiatry: antidepressants as an example. Höschl C Acta Psychiatr Scand; 2008 Aug; 118(2):89-90. PubMed ID: 18699948 [No Abstract] [Full Text] [Related]
7. Antidepressants are not placebos. Hamburg SR Am Psychol; 2000 Jul; 55(7):761-2. PubMed ID: 10916866 [No Abstract] [Full Text] [Related]
8. Pills or placebos? Fish JM Science; 1999 May; 284(5416):914-5. PubMed ID: 10357674 [No Abstract] [Full Text] [Related]
9. Active placebos in antidepressant trials. Moncrieff J; Wessely S Br J Psychiatry; 1998 Jul; 173():88. PubMed ID: 9850217 [No Abstract] [Full Text] [Related]
10. Clinical trials of antidepressant medications are producing meaningless results. Parker G; Anderson IM; Haddad P Br J Psychiatry; 2003 Aug; 183():102-4. PubMed ID: 12893662 [No Abstract] [Full Text] [Related]
11. Is loss of antidepressant effect during continuation therapy related to placebo effect? Harrison W; Stewart JW; McGrath PJ; Tricamo E; Quitkin FM Psychopharmacol Bull; 1988; 24(1):9-13. PubMed ID: 3290953 [No Abstract] [Full Text] [Related]
12. Clinical efficacy of the new antidepressant bupropion (Wellbutrin) [proceedings]. Halaris AE; Stern W; Harto-Truax N Psychopharmacol Bull; 1981 Jan; 17(1):140-2. PubMed ID: 6785817 [No Abstract] [Full Text] [Related]
13. [Placebo-controlled antidepressant drug trials. Considering the ethical implications]. Deisenhammer EA; Hinterhuber H Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755 [TBL] [Abstract][Full Text] [Related]
14. The mousetrap: managing the placebo effect in antidepressant trials. Lakoff A Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352 [No Abstract] [Full Text] [Related]
15. Venlafaxine--a new antidepressant. Med Lett Drugs Ther; 1994 Jun; 36(924):49-50. PubMed ID: 8196569 [No Abstract] [Full Text] [Related]
16. The role of antidepressants in the treatment of affective disorders. Blaine JD; Prien RF; Levine J Am J Psychother; 1983 Oct; 37(4):502-20. PubMed ID: 6318580 [TBL] [Abstract][Full Text] [Related]
17. Commentary. Clinical judgment, scientific data, and ethics: antidepressant therapy in adolescents and children. Pellegrino ED J Nerv Ment Dis; 1996 Feb; 184(2):106-8. PubMed ID: 8596106 [No Abstract] [Full Text] [Related]
18. [Evaluation studies on the efficacy of an antidepressant drug]. Boyer P Encephale; 1995 Feb; 21 Spec No 1():27-30. PubMed ID: 7729351 [No Abstract] [Full Text] [Related]
19. Can the findings of antidepressant efficacy trials be extrapolated to the general population of depressed patients? Interview by Dr. Frederic Flach. Zimmerman M Essent Psychopharmacol; 2005; 6(2):118-25. PubMed ID: 15765796 [No Abstract] [Full Text] [Related]
20. Design characteristics that influence attrition in geriatric antidepressant trials: meta-analysis. Heo M; Papademetriou E; Meyers BS Int J Geriatr Psychiatry; 2009 Sep; 24(9):990-1001. PubMed ID: 19263464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]